SCHEMBL23970943

SCHEMBL23970943

CC(=O)c1ccc2cc[nH]c2n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK8 P49336 3/20 0.41
PRKD3 O94806 2/20 0.41
MAP4K4 O95819 2/20 0.41
PAK4 O96013 2/20 0.41
PDGFRB P09619 2/20 0.41
PDGFRA P16234 2/20 0.41
LTK P29376 2/20 0.41
KDR P35968 2/20 0.41
CLK2 P49760 2/20 0.41
CDK7 P50613 2/20 0.41
CDK5 Q00535 2/20 0.41
MST1R Q04912 2/20 0.41
LRRK2 Q5S007 2/20 0.41
CLK4 Q9HAZ1 2/20 0.41
DYRK1B Q9Y463 2/20 0.41
PLK4 O00444 1/20 0.41
DCLK1 O15075 1/20 0.41
ROCK2 O75116 1/20 0.41
CHEK2 O96017 1/20 0.41
INSR P06213 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27732331 0.84 AXL (0.41) CDK8PRKD3MAP4K4PAK4PDGFRB
SCHEMBL1855794 0.82 MGAM (0.46) AXLNUDT1KDM5ABRD4TNKS
SCHEMBL19539184 0.81 CDK8 (0.43) CDK8AXLNUDT1KDM5ABRD4
SCHEMBL30487055 0.81 CDK8 (0.43) CDK8BRD4ALDH1A1KDM4E
SCHEMBL30166596 0.81 CDK8 (0.43) CDK8AXLNUDT1KDM5ABRD4
SCHEMBL1161415 0.81 CDK8 (0.43) CDK8BRD4ALDH1A1KDM4E
SCHEMBL19463620 0.81 PIM1 (0.43) CDK8CDK7AXLNUDT1KDM5A
SCHEMBL24572003 0.81 AXL (0.38) CDK8PRKD3MAP4K4PAK4PDGFRB
SCHEMBL19531834 0.78 CNR2 (0.40) SYKKDM5ATNKSNTRK1ALDH1A1
SCHEMBL21179076 0.77 KDM5A (0.37) CDK8PRKD3MAP4K4PAK4PDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115551862-B Macrocyclic inhibitors of peptidyl arginine deiminase 吉利德科学公司 2024-04-12 CN disclosed
US-20230002412-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. 2023-01-05 US disclosed
WO-2022140390-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. (US) 2022-06-30 WO disclosed
WO-2021222353-A1 MACROCYCLIC INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. (US) 2021-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002412-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES PADI4, PADI2, PADI1 CDK8 1962/4885PRKD3 345/4885MAP4K4 1312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.